Literature DB >> 30840321

The association between the Nutrition-Related index and morbidity following head and neck microsurgery.

Harman S Parhar1,2, J Scott Durham1, Donald W Anderson1, Barret Rush2,3, Eitan Prisman1.   

Abstract

OBJECTIVES/HYPOTHESIS: Despite consensus that preoperative nutritional assessment is of importance in the head and neck surgical oncology population, it remains unclear how exactly malnutrition is associated with perioperative morbidity especially among those undergoing microvascular surgery. We aimed to study this association to help inform preoperative risk stratification, guide the use of nutritional interventions, and ultimately help prevent malnutrition related morbidity. STUDY
DESIGN: Database analysis.
METHODS: Retrospective, linked analysis of the 2011 to 2016 National Surgical Quality Improvement Program. After identifying eligible patients and stratifying according to the Nutrition-Related Index, a univariate screen of preoperative demographic and clinical covariates was performed. Subsequently, propensity score matching was utilized to control for differences in baseline covariates. Perioperative complications and mortality were then analyzed using the propensity score-matched cohorts.
RESULTS: Among 977 identified patients, 276 (28.2%) were malnourished. Malnourished patients had higher rates of comorbidity, were more likely to actively smoke, and were more likely to have primaries in the oropharynx or hypopharynx/larynx. After propensity score matching to control for confounders, malnourished patients had higher rates of pulmonary complications (21.5% vs. 11.6%, P < .01), higher rates of bleeding or need for transfusion (56.6% vs. 43.0%, P < .01), higher rates of venous thromboembolism (3.7% vs. 0.8%, P = .03), and a higher 30-day mortality rates (3.7% vs. 0.0%, P < .01).
CONCLUSIONS: This nationwide analysis finds that 28.2% of patients undergoing surgery for head and neck cancers with free flap reconstruction are malnourished. Malnourishment was found to be independently associated with postoperative pulmonary complications, bleeding or need for transfusion, and 30-day mortality. LEVEL OF EVIDENCE: NA Laryngoscope, 130:375-380, 2020.
© 2019 The American Laryngological, Rhinological and Otological Society, Inc.

Entities:  

Keywords:  Head and neck surgery; nutrition; preoperative optimization; quality improvement

Mesh:

Year:  2019        PMID: 30840321     DOI: 10.1002/lary.27912

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  5 in total

Review 1.  Nutritional prehabilitation in head and neck cancer: a systematic review.

Authors:  Linda A Cantwell; Emer Fahy; Emily R Walters; Joanne M Patterson
Journal:  Support Care Cancer       Date:  2022-08-01       Impact factor: 3.359

2.  The Impact of Healthcare-Associated Infections in Patients Undergoing Oncological Microvascular Head and Neck Reconstruction: A Prospective Multicentre Study.

Authors:  Ana Ramos-Zayas; Francisco López-Medrano; Irene Urquiza-Fornovi; Ignacio Zubillaga; Ramón Gutiérrez; Gregorio Sánchez-Aniceto; Julio Acero; Fernando Almeida; Ana Galdona; María José Morán; Marta Pampin; José Luis Cebrián
Journal:  Cancers (Basel)       Date:  2021-04-27       Impact factor: 6.639

3.  Therapeutic Perspectives for the Perioperative Period in Oral Squamous Cell Carcinoma (OSCC).

Authors:  Antoine Galmiche; Zuzana Saidak; Jérémie Bettoni; Martial Ouendo; Sylvie Testelin
Journal:  Front Oral Health       Date:  2022-01-11

4.  Enhanced Recovery After Surgery Nutrition Protocol for Major Head and Neck Cancer Surgery.

Authors:  Cindy Moore; J'undra Pegues; Vamsi Narisetty; Christopher Spankovich; Lana Jackson; Gina D Jefferson
Journal:  OTO Open       Date:  2021-06-18

5.  Nutrition delivery after emergency laparotomy in surgical ward: a retrospective cohort study.

Authors:  Sanna Lahtinen; Aura Ylimartimo; Juho Nurkkala; Timo Kaakinen; Merja Vakkala; Marjo Koskela; Janne Liisanantti
Journal:  Eur J Trauma Emerg Surg       Date:  2021-04-02       Impact factor: 3.693

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.